Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
SmiLe company Saga Diagnostics has been chosen following tough competition to be awarded a grant through Swelife’s “Project for better health, step 2” and will receive SEK 4.7 million. In addition to being a member of SmiLe Incubator, Saga is included in LU Holding’s portfolio of companies. Of the 22 projects that were evaluated, only eight receive funding and half of them come from Lund.
Sinntaxis in Lund has been awarded SEK 500,000 under the SME instrument phase 1 program within the EU Horizon 2020 framework. The grant money will be used to advance the business plan and the regulatory work to initiate a phase II clinical trial in stroke recovery.
Donations include $30 million to Communities In Schools, $10 million to City Year and $15 million to University of Chicago Education Lab. The contributions will significantly expand and strengthen programs to provide vulnerable children across the country with academic, social and emotional support to help them achieve their full potential.
In2cure’s founder has received SEK 950,000 from the Swedish Research Council for development of the drug candidate BioC, which will be used to promote wound healing. The In2cure project received consistently high scores in the Research Council’s assessment.
InDex Pharmaceuticals Holding AB (publ) today announced the composition of the Nomination Committee for the 2019 Annual General Meeting, which will be held on Monday May 6, 2019. The responsibility of the Nomination Committee is to present to the 2019 Annual General Meeting proposals regarding election of the Chairman of the Board and other members of the Board, fees and any other remuneration to the members of the Board as well as election and remuneration of the auditors.
The board of directors of InDex Pharmaceuticals Holding AB (publ) (the “Company” or “InDex”) has, with support from the authorization granted by the annual general meeting on May 24, 2018, resolved on a directed share issue of 6,252,842 shares to a small group of investors.